Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Lowered to $270 at Oppenheimer

April 19, 2024 7:22 AM
(Updated - April 19, 2024 7:25 AM EDT)

Oppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change